TD Securities (USA)’s AbbVie ABBV Stock Holding History

TD Securities (USA)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$21K	Sell	364 -3	-0.8%	-$167	0.19%	45
2015 Q4	$22K	Sell	367 -579	-61%	-$33.3K	0.2%	43
2015 Q3	$51K	Sell	946 -695,468	-100%	-$45.3M	0.47%	43
2015 Q2	$46.8M	Buy	696,414 +123,829	+22%	+$8.08M	0.63%	36
2015 Q1	$33.5M	Sell	572,585 -32,431	-5%	-$1.96M	0.5%	48
2014 Q4	$39.6M	Buy	605,016 +48,257	+9%	+$3.04M	0.57%	39
2014 Q3	$32.2M	Buy	556,759 +903	+0.2%	+$50.1K	0.52%	40
2014 Q2	$31.4M	Buy	555,856 +34,568	+7%	+$1.81M	0.5%	39
2014 Q1	$26.8M	Sell	521,288 -39,988	-7%	-$2.02M	0.48%	45
2013 Q4	$29.6M	Buy	561,276 +18,448	+3%	+$907K	0.5%	44
2013 Q3	$24.3M	Buy	542,828 +2,821	+0.5%	+$125K	0.46%	46
2013 Q2	$22.3M	Buy	+540,007	New	+$23.6M	0.44%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TD Securities (USA)'s ABBV Position: Q1 2016 in Review

TD Securities (USA) reduced its AbbVie (ABBV) stake by 0.82% in Q1 2016, selling an estimated $167 and leaving 364 shares worth $21K. The position accounts for 0.19% of the portfolio, ranked #45.

TD Securities (USA) first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $46.8M in Q2 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

TD Securities (USA) held 364 shares of AbbVie worth $21K as of Q1 2016.
TD Securities (USA) sold 3 AbbVie shares in Q1 2016, an estimated $167.
AbbVie made up 0.19% of TD Securities (USA)'s portfolio in Q1 2016, its #45 holding.
TD Securities (USA) first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
TD Securities (USA)'s AbbVie position peaked at $46.8M in Q2 2015.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.